Pyruvate Kinase M2 is a Target of the Tumor-suppressive MicroRNA-326 and Regulates the Survival of Glioma Cells

Overview

Journal Neuro Oncol

Publisher Oxford University Press

Specialties Neurology
Oncology

Date 2010 Jul 30

PMID 20667897

Citations 125

Authors

Benjamin Kefas

Laurey Comeau

Nicholas Erdle

Emmitt Montgomery

Samson Amos

Benjamin Purow

Affiliations

Soon will be listed here.

Abstract

Emerging studies have identified microRNAs (miRNAs) as possible therapeutic tools for the treatment of glioma, the most aggressive brain tumor. Their important targets in this tumor are not well understood. We recently found that the Notch pathway is a target of miRNA-326. Ectopic expression of miRNA-326 in glioma and glioma stem cells induced their apoptosis and reduced their metabolic activity. Computational target gene prediction revealed pyruvate kinase type M2 (PKM2) as another target of miRNA-326. PKM2 has recently been shown to play a key role in cancer cell metabolism. To investigate whether it might be a functionally important target of miR-326, we used RNA interference to knockdown PKM2 expression in glioma cells. Transfection of the established glioma and glioma stem cells with PKM2 siRNA reduced their growth, cellular invasion, metabolic activity, ATP and glutathione levels, and activated AMP-activated protein kinase. The cytotoxic effects exhibited by PKM2 knockdown in glioma and glioma stem cells were not observed in transformed human astrocytes. Western blot analysis of human glioblastoma specimens showed high levels of PKM2 protein, but none was observed in normal brain samples. Strikingly, cells with high levels of PKM2 expressed lower levels of miR-326, suggestive of endogenous regulation of PKM2 by miR-326. Our data suggest PKM2 inhibition as a therapy for glioblastoma, with the potential for minimal toxicity to the brain.

Citing Articles

Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles Induced by Advanced Glycation End Products on Energy Metabolism in Vascular Endothelial Cells.

Liang J, Cheng S, Song Q, Tang Y, Wang Q, Chen H Kidney Int Rep. 2025; 10(1):227-246.

PMID: 39810759 PMC: 11725971. DOI: 10.1016/j.ekir.2024.10.015.

Practical immunomodulatory landscape of glioblastoma multiforme (GBM) therapy.

Norollahi S, Yousefi B, Nejatifar F, Yousefzadeh-Chabok S, Rashidy-Pour A, Samadani A J Egypt Natl Canc Inst. 2024; 36(1):33.

PMID: 39465481 DOI: 10.1186/s43046-024-00240-4.

Adaptive Expression and ncRNA Regulation of Genes Related to Digestion and Metabolism in Stomach of Red Pandas during Suckling and Adult Periods.

Li L, Zhang L, Luo L, Shen F, Zhao Y, Wu H Animals (Basel). 2024; 14(12).

PMID: 38929414 PMC: 11200446. DOI: 10.3390/ani14121795.

Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy.

Wang S, Gu S, Chen J, Yuan Z, Liang P, Cui H Biomolecules. 2024; 14(4).

PMID: 38672496 PMC: 11048644. DOI: 10.3390/biom14040480.

Oxaloacetate as a Holy Grail Adjunctive Treatment in Gliomas: A Revisit to Metabolic Pathway.

Samad A, Samant R, Venkateshwara Rao K, Bhargava V, Sadique S, Yadav R Cureus. 2023; 15(11):e48821.

PMID: 38106701 PMC: 10722244. DOI: 10.7759/cureus.48821.

References

Christofk H, Vander Heiden M, Harris M, Ramanathan A, Gerszten R, Wei R . The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008; 452(7184):230-3. DOI: 10.1038/nature06734. View

Christofk H, Vander Heiden M, Wu N, Asara J, Cantley L . Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature. 2008; 452(7184):181-6. DOI: 10.1038/nature06667. View

Atkinson D, Walton G . Adenosine triphosphate conservation in metabolic regulation. Rat liver citrate cleavage enzyme. J Biol Chem. 1967; 242(13):3239-41. View

Yekta S, Shih I, Bartel D . MicroRNA-directed cleavage of HOXB8 mRNA. Science. 2004; 304(5670):594-6. DOI: 10.1126/science.1097434. View

Chang T, Wentzel E, Kent O, Ramachandran K, Mullendore M, Lee K . Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007; 26(5):745-52. PMC: 1939978. DOI: 10.1016/j.molcel.2007.05.010. View

Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N . Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell. 2007; 26(5):731-43. DOI: 10.1016/j.molcel.2007.05.017. View

Inoki K, Zhu T, Guan K . TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003; 115(5):577-90. DOI: 10.1016/s0092-8674(03)00929-2. View

Kefas B, Heimberg H, Vaulont S, Meisse D, Hue L, Pipeleers D . AICA-riboside induces apoptosis of pancreatic beta cells through stimulation of AMP-activated protein kinase. Diabetologia. 2003; 46(2):250-4. DOI: 10.1007/s00125-002-1030-3. View

Grahame Hardie D . AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol. 2007; 8(10):774-85. DOI: 10.1038/nrm2249. View

10.

He L, He X, Lim L, de Stanchina E, Xuan Z, Liang Y . A microRNA component of the p53 tumour suppressor network. Nature. 2007; 447(7148):1130-4. PMC: 4590999. DOI: 10.1038/nature05939. View

11.

Chan J, Krichevsky A, Kosik K . MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005; 65(14):6029-33. DOI: 10.1158/0008-5472.CAN-05-0137. View

12.

Hitosugi T, Kang S, Vander Heiden M, Chung T, Elf S, Lythgoe K . Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal. 2009; 2(97):ra73. PMC: 2812789. DOI: 10.1126/scisignal.2000431. View

13.

Murchison E, Hannon G . miRNAs on the move: miRNA biogenesis and the RNAi machinery. Curr Opin Cell Biol. 2004; 16(3):223-9. DOI: 10.1016/j.ceb.2004.04.003. View

14.

Li Y, Guessous F, Zhang Y, diPierro C, Kefas B, Johnson E . MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009; 69(19):7569-76. PMC: 2756313. DOI: 10.1158/0008-5472.CAN-09-0529. View

15.

Brooks Robey R, Hay N . Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol. 2009; 19(1):25-31. PMC: 2814453. DOI: 10.1016/j.semcancer.2008.11.010. View

16.

Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin N . Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 2006; 9(5):391-403. DOI: 10.1016/j.ccr.2006.03.030. View

17.

Kefas B, Comeau L, Floyd D, Seleverstov O, Godlewski J, Schmittgen T . The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. J Neurosci. 2009; 29(48):15161-8. PMC: 2823067. DOI: 10.1523/JNEUROSCI.4966-09.2009. View

18.

Mukherjee P, Mulrooney T, Marsh J, Blair D, Chiles T, Seyfried T . Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brain. Mol Cancer. 2008; 7:37. PMC: 2397440. DOI: 10.1186/1476-4598-7-37. View

19.

Mazurek S, Grimm H, Wilker S, Leib S, Eigenbrodt E . Metabolic characteristics of different malignant cancer cell lines. Anticancer Res. 1998; 18(5A):3275-82. View

20.

Dombrauckas J, Santarsiero B, Mesecar A . Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry. 2005; 44(27):9417-29. DOI: 10.1021/bi0474923. View